Vaccine Maker Bankruptcy Shows Regulatory Perils Of Business In China

China's Changchun Changsheng Biotech has been officially declared bankrupt, ending long-running speculation. The major vaccine maker’s dramatic fall has several take-away lessons for health companies operating in China, where several new regulations are taking effect.

Business decline
CHANGSHENG BIO'S INSOLVENCY SHOWS REGULATORY TIGHTENING IN CHINA HEALTH SECTOR • Source: Shutterstock

More from China

More from Asia